144 related articles for article (PubMed ID: 34739644)
1. AFP peptide (AFPep) as a potential growth factor for prostate cancer.
Zhu Z; West GR; Wang DC; Collins AB; Xiao H; Bai Q; Mesfin FB; Wakefield MR; Fang Y
Med Oncol; 2021 Nov; 39(1):2. PubMed ID: 34739644
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
3. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties.
Mansouri W; Fordyce SB; Wu M; Jones D; Cohn D; Lin Q; Feustel P; Sharma T; Bennett JA; Andersen TT
Toxicol Appl Pharmacol; 2018 Apr; 345():10-18. PubMed ID: 29518411
[TBL] [Abstract][Full Text] [Related]
5. AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Tower AM; Trinward A; Lee K; Joseph L; Jacobson HI; Bennett JA; Andersen TT
Oncol Rep; 2009 Jul; 22(1):49-56. PubMed ID: 19513504
[TBL] [Abstract][Full Text] [Related]
6. AFPep: an anti-breast cancer peptide that is orally active.
Bennett JA; DeFreest L; Anaka I; Saadati H; Balulad S; Jacobson HI; Andersen TT
Breast Cancer Res Treat; 2006 Jul; 98(2):133-41. PubMed ID: 16538538
[TBL] [Abstract][Full Text] [Related]
7. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
8. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
Zhang H; Lü JJ; Gao QZ; Zhang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
[TBL] [Abstract][Full Text] [Related]
9. An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.
Andersen TT; Georgekutty J; Defreest LA; Amaratunga G; Narendran A; Lemanski N; Jacobson HI; Bennett JA
Br J Cancer; 2007 Aug; 97(3):327-33. PubMed ID: 17637684
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
[TBL] [Abstract][Full Text] [Related]
11. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
13. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells.
Zhang JF; Yan XM; Lan B; Lei YR; Li XH; Gao S; Guo YF; Guo F
Biochem Biophys Res Commun; 2016 Oct; 479(2):159-165. PubMed ID: 27524236
[TBL] [Abstract][Full Text] [Related]
15. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis.
Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL
Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Effects of Guava (
Lin HC; Lin JY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807287
[TBL] [Abstract][Full Text] [Related]
18. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer.
Jacobson HI; Andersen TT; Bennett JA
Cancer Prev Res (Phila); 2014 Jun; 7(6):565-73. PubMed ID: 24706695
[TBL] [Abstract][Full Text] [Related]
19. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin prevents apoptosis in prostate cancer cells.
Abasolo I; Montuenga LM; Calvo A
Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
